G01N 2800/105
Osteoarthritis
Official title: Osteoarthritis, e.g. cartilage alteration, hypertrophy of bone
G01N2800/105 (Osteoarthritis) appears on 155 US grants and 227 published applications in this corpus.
Search patents in G01N- Granted patents
- 155
- Published applications
- 227
- Assignees
- 156
- Inventors
- 481
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 2 | 0 |
| 1995 | 3 | 0 |
| 1996 | 3 | 0 |
| 1997 | 7 | 0 |
| 1998 | 4 | 0 |
| 1999 | 7 | 0 |
| 2000 | 9 | 0 |
| 2001 | 2 | 1 |
| 2002 | 1 | 7 |
| 2003 | 8 | 4 |
| 2004 | 2 | 5 |
| 2005 | 2 | 5 |
| 2006 | 2 | 5 |
| 2007 | 1 | 13 |
| 2008 | 0 | 10 |
| 2009 | 1 | 12 |
| 2010 | 5 | 14 |
| 2011 | 3 | 13 |
| 2012 | 5 | 10 |
| 2013 | 10 | 9 |
| 2014 | 10 | 10 |
| 2015 | 3 | 9 |
| 2016 | 2 | 15 |
| 2017 | 7 | 10 |
| 2018 | 10 | 6 |
| 2019 | 4 | 12 |
| 2020 | 9 | 12 |
| 2021 | 6 | 4 |
| 2022 | 7 | 6 |
| 2023 | 4 | 14 |
| 2024 | 5 | 5 |
| 2025 | 5 | 9 |
| 2026 | 2 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Anti-OSCAR antibody for preventing or treating osteoarthritis16 Jun 2026US 12,655,215 B2Ewha University-Industry Collaboration Foundation
- Biomarkers of early osteoarthritis16 Jun 2026US 12,656,343 B2CD Diagnostics, Inc.
- Collagen type X alpha-1 assay22 Jul 2025US 12,366,582 B2Nordic Bioscience A/S
- Metabolic biomarkers for predicting responsiveness to FGF-18 compound17 Jun 2025US 12,332,251 B2Merck Patent GmbH
- Compositions and methods for diagnosing and assessing rheumatoid arthritis13 May 2025US 12,298,304 B2Inova Diagnostics, Inc.
- Electrochemical biosensors, systems, and methods of use8 Oct 2026US 2026/0309671 A1
- C3F Assay10 Sep 2026US 2026/0266829 A1Nordic Bioscience A/S
- Pharmaceutical composition for prevention or treatment of age-related musculoskeletal disorders20 Aug 2026US 2026/0240871 A1Seoul National University R&Db Foundation
- Chondroitin Sulfate and Heparan Sulfate as Biomarkers for Discriminating Osteoarthritis and Rheumatoid Arthritis11 Jun 2026US 2026/0160757 A1Elypta AB
- Compositions, devices, and methods of osteoarthritis sensitivity testing12 Mar 2026US 2026/0072016 A1
Most cited
By later US patents
- Peptide fragments containing HP and LP cross-links46US 5,140,103 AWashington Research Foundation · 1992
- Peptide fragments containing HP and LP cross-links45US 4,973,666 AWashington Research Foundation · 1990
- Hybridoma cell line producing an antibody to type-I collagen amino-terminal telopeptide44US 5,300,434 AWashington Research Foundation · 1994
- Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass35US 7,005,274 B1Migenix Inc. · 2006
- Methods of detecting collagen degradation in vivo34US 5,532,169 AWashington Research Foundation · 1996